
Pharmaceutical Technology Europe
There have been significant advances, especially in understanding the role of carrier properties on the aerosol performance of the API.

Pharmaceutical Technology Europe
There have been significant advances, especially in understanding the role of carrier properties on the aerosol performance of the API.

Pharmaceutical Technology Europe
The presence of very low levels of residues (including solvents) in excipients is becoming an important issue for users, and the presence of very low levels of ?non-lactose? species in DPI lactose may pose challenges to suppliers and users.

October 1st 2006